Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Kidney function can improve in patients with hypertensive CKD.

Hu B, Gadegbeku C, Lipkowitz MS, Rostand S, Lewis J, Wright JT, Appel LJ, Greene T, Gassman J, Astor BC; African-American Study of Kidney Disease and Hypertension Group.

J Am Soc Nephrol. 2012 Apr;23(4):706-13. doi: 10.1681/ASN.2011050456. Epub 2012 Mar 8.

2.

A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.

Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT Jr; AASK Study Group.

J Am Soc Nephrol. 2004 Dec;15(12):3175-83.

3.

Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients.

Masugata H, Senda S, Inukai M, Himoto T, Murao K, Hosomi N, Iwado Y, Noma T, Kohno M, Goda F.

Tohoku J Exp Med. 2011;224(2):137-42.

4.

Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.

Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, Oreopoulos DG.

Int Urol Nephrol. 2009 Dec;41(4):977-82. doi: 10.1007/s11255-009-9604-3. Epub 2009 Jul 4.

PMID:
19578968
5.

Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ.

Nephrol Dial Transplant. 2015 Aug;30(8):1329-35. doi: 10.1093/ndt/gfv037. Epub 2015 Mar 27.

PMID:
25817226
6.

A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings.

Rule AD, Jacobsen SJ, Schwartz GL, Mosley TH, Scott CG, Kardia SL, Boerwinkle E, Turner ST.

Am J Hypertens. 2006 Jun;19(6):608-14.

PMID:
16733233
7.

The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.

8.

Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.

Erickson KF, Lea J, McClellan WM.

Clin J Am Soc Nephrol. 2013 Jan;8(1):75-81. doi: 10.2215/CJN.03340412. Epub 2012 Oct 18.

9.

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.

PMID:
23993165
10.

Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.

Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, Ogawa T, Uchida K, Tsuchiya K, Nitta K.

Intern Med. 2008;47(21):1859-64. Epub 2008 Nov 4.

11.

Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.

Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR; Alberta Kidney Disease Network.

Am J Kidney Dis. 2012 Aug;60(2):241-9. doi: 10.1053/j.ajkd.2012.03.016. Epub 2012 May 4.

PMID:
22560843
12.

Mortality risk stratification in chronic kidney disease: one size for all ages?

O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC.

J Am Soc Nephrol. 2006 Mar;17(3):846-53. Epub 2006 Feb 1.

13.

Longitudinal progression trajectory of GFR among patients with CKD.

Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH.

Am J Kidney Dis. 2012 Apr;59(4):504-12. doi: 10.1053/j.ajkd.2011.12.009. Epub 2012 Jan 26.

14.

Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations.

Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, Boa FG, Banerjee D, Emmett L, Miller MA, Cappuccio FP.

Nephrol Dial Transplant. 2010 Jul;25(7):2178-87. doi: 10.1093/ndt/gfp765. Epub 2010 Jan 25. Erratum in: Nephrol Dial Transplant. 2011 Dec;26(12):4153. Emmett, Lynsey [added]; Miller, Michelle A [added].

16.

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL.

Arch Intern Med. 2005 Apr 25;165(8):947-53.

PMID:
15851648
17.

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group.

Am J Kidney Dis. 2006 Nov;48(5):739-51.

PMID:
17059993
18.

Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease.

de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H.

Nephron Clin Pract. 2011;117(3):c213-24. doi: 10.1159/000320341. Epub 2010 Aug 31. Erratum in: Nephron Clin Pract. 2012;120(2):c107.

PMID:
20805694
19.

Renal function can improve at any stage of chronic kidney disease.

Weis L, Metzger M, Haymann JP, Thervet E, Flamant M, Vrtovsnik F, Gauci C, Houillier P, Froissart M, Letavernier E, Stengel B, Boffa JJ; NephroTest Study Group.

PLoS One. 2013 Dec 13;8(12):e81835. doi: 10.1371/journal.pone.0081835. eCollection 2013.

20.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk